ClinicalTrialsFinder

Moderate to Severe Allergic Asthma Clinical Trials in Nanjing, Jiangsu

1 recruitingNanjing, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting

A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)

Moderate to Severe Allergic Asthma
The First Affiliated Hospital with Nanjing Medical University300 enrolled1 locationNCT06348407